Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron Oral Soluble Film vs IV for Pediatric CINV
NCT06208917Phase 3Recruiting
- Start
- Jul 2023
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ondansetron in chemotherapy-induced nausea and vomiting (CINV). Started Jul 2023; status: recruiting.
02
Drugs
ondansetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT06208917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06208917.